New York, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Atopic Eczema Treatment Market - By Drug Class (Biologics And PDE4 Inhibitors), By Route Of Administration (Topical, Injectable, And Oral), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.
“According to the latest research study, the demand of global Atopic Eczema Treatment Market size & share in terms of revenue was valued at USD 10 billion in 2022 and it is expected to surpass around USD 13 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 7.14% during the forecast period 2023 to 2030.”
What is Atopic Eczema Treatment? How big is the Atopic Eczema Treatment Industry?
Report Overview:
The global atopic eczema treatment market size was evaluated at $10 billion in 2022 and is slated to hit $13 billion by the end of 2030 with a CAGR of nearly 7.14% between 2023 and 2030.
Atopic eczema is a form of eczema that affects the skin and causes it to become dry, cracked, and itchy. In addition, atopic eczema can be treated, and the treatment itself is referred to as a comprehensive strategy for the treatment of atopic eczema. Rehydrating the skin using ointments and topical steroids is part of the treatment for atopic eczema, which also aims to relieve inflammation and itching caused by the condition. The condition has aspects that are controllable, such as inhalant and food allergies, as well as aspects that are not modifiable, such as inherited characteristics.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.zionmarketresearch.com/sample/atopic-eczema-treatment-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 219+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Zion Market Research research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Global Atopic Eczema Treatment Market: Growth Factors
An increase in the number of people suffering from skin conditions is expected to drive global market trends over the next few years.
The demand for treatment for atopic eczema has been stoked by an increase in the number of cases of skin disorders found in both children and adults as well as the necessity of properly addressing these diseases. The expansion of the global market for atopic eczema treatment will be further driven by a jump in the level of knowledge among individuals regarding the treatment of the illness. The size of the market in every region of the world will increase as a result of advantageous government programs and promotions pertaining to the treatment of skin disorders. The global market trends will be driven by an increase in the utilization of medications such as antibiotics and corticosteroids in the treatment of eczema.
In the years ahead, encouraging compensation policies will be the primary factor driving the growth of the market in every region of the world. In the years to come, the introduction of new products is projected to play a significant role in driving growth in the global market. For instance, in the first half of 2022, Sanofi S.A., a major healthcare company located in France, launched dupilumab for the treatment of atopic eczema in children aged between 6 months and 5 years old. The drug gained the go-ahead from the Food and Drug Administration (FDA) in the United States. These kinds of moves almost certainly will increase the size of the worldwide market in the years to come.
The Challenges Facing the Atopic Eczema Treatment Market
An increase in the costs of skin order treatments has the potential to impede the expansion of the global industry over the forecast period.
An increase in the cost of treatment has the potential to slow the expansion of the atopic eczema treatment sector around the world. Long-term therapy and frequent hospital visits may prove to be cumbersome and burdensome for patients, which may result in a decrease in demand across the global business.
Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/atopic-eczema-treatment-market
Report Scope
| Report Attribute | Details |
| Market Size in 2022 | USD 10 billion |
| Projected Market Size in 2030 | USD 13 billion |
| CAGR Growth Rate | 7.14% CAGR |
| Base Year | 2022 |
| Forecast Years | 2023-2030 |
| Key Market Players | Pfizer Inc., AbbVie Inc., GALDERMA LABORATORIES, L.P., Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Incyte Corporation, Sanofi, Novartis AG, Eli Lilly and Company (Dermira), LEO Pharma Inc., and others. |
| Key Segment | By Drug Class, By Route of Administration, and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Atopic Eczema Treatment Market: Segmentation Analysis
The market for the treatment of atopic eczema can be broken down into three categories: drug class, route of administration, and area.
The global market for the treatment of atopic eczema may be broken down into two different groups based on the pharmacological class: biologics and PDE4 inhibitors. In addition, the biologics category, which accounted for almost half of the total revenue share of the global market in 2022, is anticipated to record the highest CAGR over the course of the following years. It's possible that the capacity of biologics to target skin inflammations is what's driving the rise of this sector in the timeframe that's been projected.
The global market for atopic eczema treatments may be broken down into three distinct segments: injectable, topical, and oral. These divisions are based on the method of administration. In addition, the injectable sector, which accounted for a significant proportion of the global industry's revenue share in 2022, is anticipated to take the lead in the global market throughout the course of the analysis period. Injectable medications like dupilumab are becoming increasingly popular, while ruxolitinib and tofacitinib are being used extensively in the treatment of a wide variety of skin conditions, including eczema. These factors may have contributed to the growth of this particular market segment throughout the course of the evaluation period.
The global Atopic Eczema Treatment market is segmented as follows:
By Drug Class
- Biologics
- PDE4 Inhibitors
By Route of Administration
- Topical
- Injectable
- Oral
Browse the full “Atopic Eczema Treatment Market - By Drug Class (Biologics And PDE4 Inhibitors), By Route Of Administration (Topical, Injectable, And Oral), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030" Report At https://www.zionmarketresearch.com/report/atopic-eczema-treatment-market
Competitive Landscape
Some of the main competitors dominating the global Atopic Eczema Treatment market include -
- Pfizer Inc.
- AbbVie Inc.
- GALDERMA LABORATORIES
- L.P.
- Otsuka Pharmaceutical Co. Ltd.
- Regeneron Pharmaceuticals Inc.
- Incyte Corporation
- Sanofi
- Novartis AG
- Eli Lilly and Company (Dermira)
- LEO Pharma Inc.
Key Insights from Primary Research:
- According to the analysis shared by our research forecaster, the Atopic Eczema Treatment market is likely to expand at a CAGR of around 7.14% during the forecast period (2023-2030).
- In terms of revenue, the Atopic Eczema Treatment market size was valued at around US$ 10 billion in 2022 and is projected to reach US$ 13 billion by 2030.
- The global atopic eczema treatment market is anticipated to grow rapidly over the forecast timeline owing to the rise in the incidences of skin diseases in children and adult populations and the need for effectively curing them.
- In terms of drug class, the biologics segment is slated to register the highest CAGR over the analysis period.
- Based on the route of administration, the injectable segment is expected to dominate the segmental growth over the assessment timeline.
- Region-wise, the Asia-Pacific atopic eczema treatment industry is projected to register the fastest CAGR during the assessment timeline.
Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/atopic-eczema-treatment-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Atopic Eczema Treatment industry?
- What are the main driving factors propelling the Atopic Eczema Treatment Market forward?
- What are the leading companies in the Atopic Eczema Treatment Industry?
- What segments does the Atopic Eczema Treatment Market cover?
- How can I receive a free copy of the Atopic Eczema Treatment Market sample report and company profiles?
Key Offerings:
- Market Size & Forecast by Revenue | 2023−2030
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis By Drug Class, By Route of Administration, and By Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/7587
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
North America is anticipated to retain a dominating position in the global Atopic Eczema Treatment market over the anticipated timeline
North America, which contributed about half of the global atopic eczema treatment market revenue in 2022, will be a leading region over the projected timeframe. Furthermore, the regional market growth can be subject to a rise in the presence of giant firms such as AbbVie as well as Viatris in the countries such as the U.S. Furthermore, additionally, the availability of strong healthcare infrastructure facilities and increase in the healthcare spending favorably impact the regional market expansion.
Asia-Pacific atopic eczema treatment industry is set to register the fastest CAGR in the forthcoming years owing to favorable healthcare policies of governments in countries such as India and China. Moreover, a rise in the availability of effective treatment at reasonable costs in these countries will drive regional industry trends.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/atopic-eczema-treatment-market
Browse Other Related Research Reports from Zion Market Research:
Patient Handling Equipment Market: https://www.zionmarketresearch.com/report/patients-handling-equipment-market
Personal Protective Equipment Market: https://www.zionmarketresearch.com/report/personal-protective-equipment-market
Point-Of-Sale (POS) Terminals Market: https://www.zionmarketresearch.com/report/point-of-sale-terminals-market
Platelet Aggregation Devices Market: https://www.zionmarketresearch.com/report/platelet-aggregation-devices-market
Tissue Banking Market: https://www.zionmarketresearch.com/report/tissue-banking-market
Personal Cloud Market: https://www.zionmarketresearch.com/report/personal-cloud-market
Plant Factory Grow Lights Market: https://www.zionmarketresearch.com/report/plant-factory-grow-lights-market
Vegan Chocolate Confectionery Market: https://www.zionmarketresearch.com/report/vegan-chocolate-confectionery-market
Nutritional Supplements Market: https://www.zionmarketresearch.com/report/nutritional-supplements-market
Prefabricated Housing Market: https://www.zionmarketresearch.com/report/prefabricated-housing-market
Pain Management Devices Market: https://www.zionmarketresearch.com/report/pain-management-devices-market
Osteoporosis Drugs Market: https://www.zionmarketresearch.com/report/osteoporosis-drugs-market
Palm Methyl Ester Market: https://www.zionmarketresearch.com/report/palm-methyl-ester-market
Para Toluene Sulfonyl Hydrazide Market: https://www.zionmarketresearch.com/report/para-toluene-sulfonyl-hydrazide-market
Palm Kernel Oil Market: https://www.zionmarketresearch.com/report/palm-kernel-oil-market
Canned Alcoholic Beverages Market: https://www.zionmarketresearch.com/report/canned-alcoholic-beverages-market
Pharmaceutical Logistics Market: https://www.zionmarketresearch.com/report/pharmaceutical-logistics-market
Polymer Foam Market: https://www.zionmarketresearch.com/report/polymer-foam-market
Furfural Market: https://www.zionmarketresearch.com/report/furfural-market
Fungicides Market: https://www.zionmarketresearch.com/report/fungicides-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us to deliver always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/
Follow Us on Twitter: https://twitter.com/zion_research
Follow Us on Facebook: https://www.facebook.com/zionmarketresearch
Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/
Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs
Contact Us:
Zion Market Research
USA/Canada Toll Free: 1 (855) 465-4651
Newark: 1 (302) 444-0166
India: +91 7768 006 007, +91 7768 006 008
Skype no: +13479038971, +17187054574
Skype no. United Kingdom: +442032894158
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: sales@zionmarketresearch.com
